ArticlePloS one2024
Single-step hydrothermal synthesis of zinc oxide nanorods for potential use as nano-antibiotics without seeding or bases.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The alarming global rise in antibiotic resistance, driven by the widespread overuse of traditional antibiotics, has created an urgent demand for new antimicrobial solutions. This study presents zinc oxide (ZnO) nanorods as a potential nano-antibiotic agent. ZnO nanorods, with a 2:3 aspect ratio, were synthesized using an efficient one-step hydrothermal method at a low temperature of 100°C, reducing the synthesis time to just 5 hours. The synthesized ZnO nanorods' morphology, structure, and composition were characterized using scanning electron microscopy, x-ray diffraction, and energy dispersive x-ray spectroscopy. The potent antimicrobial activity of these nanorods against common bacterial strains such as Escherichia coli, Bacillus subtilis, and Vibrio parahaemolyticus was examined through optical density at 600 nm (OD600) measurements and inhibition zone analysis, demonstrating substantial inhibition of bacterial growth. In particular, at a concentration of 5 mg/mL, ZnO nanorods achieved a 96% reduction of B. subtilis bacteria in OD600 and an impressive 99.87% reduction in culturing assays within one day, showcasing bactericidal efficiency on par with tetracycline at 0.003 mg/mL. Furthermore, a predictive model of bacterial growth was developed and validated, providing insights into the time-dependent bactericidal efficiency of the synthesized nanorods. These results highlight the potential of ZnO-based composites as a promising solution to combat antibiotic resistance, paving the way for next-generation antimicrobial materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.